Medicare Enrolled
Dr. Farrel Douglas, MD
Neurology · Fall River, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Douglas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Douglas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Douglas
Dr. Farrel Douglas is a neurology specialist in Fall River, MA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Douglas performed 721 Medicare services across 577 unique beneficiaries.
Between the years covered by Open Payments, Dr. Douglas received a total of $18,409 from 74 pharmaceutical and/or device companies across 944 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Douglas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 21% volume in MA
$18,409 industry payments
Medicare Practice Summary
Medicare Utilization ↗721
Medicare services
Top 21% in MA for neurology
577
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~34 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
320 | $136 | $470 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
67 | $26 | $105 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
60 | $8 | $17 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
41 | $10 | $36 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
37 | $8 | $26 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
34 | $15 | $51 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
29 | $29 | $99 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
26 | $16 | $58 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
24 | $14 | $50 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
21 | $5 | $17 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
19 | $132 | $499 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
16 | $121 | $474 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
14 | $9 | $31 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
13 | $13 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,409
Total received (2018-2024)
Avg $2,630/year across 7 years
Top 19% in MA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
944
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,533 (95.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$876 (4.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,326
2023
$3,959
2022
$2,612
2021
$1,143
2020
$883
2019
$3,396
2018
$3,090
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
MDD US Operations, LLC
$558
EMD Serono, Inc.
$388
UCB, Inc.
$266
ABBVIE INC.
$243
Teva Pharmaceuticals USA, Inc.
$198
PFIZER INC.
$193
Lilly USA, LLC
$137
Novartis Pharmaceuticals Corporation
$135
CATALYST PHARMACEUTICALS, INC.
$130
Sumitomo Pharma America, Inc.
$114
SK Life Science, Inc.
$110
Takeda Pharmaceuticals U.S.A., Inc.
$96
CSL Behring
$88
Alexion Pharmaceuticals, Inc.
$79
Otsuka America Pharmaceutical, Inc.
$71
Mallinckrodt Hospital Products Inc.
$67
Lundbeck LLC
$60
SCILEX PHARMACEUTICALS INC.
$47
Axsome Therapeutics, Inc.
$45
Genentech USA, Inc.
$37
Celgene Corporation
$31
E.R. Squibb & Sons, L.L.C.
$30
Biogen, Inc.
$29
Kyowa Kirin, Inc.
$27
Vanda Pharmaceuticals Inc.
$25
Neurelis, Inc.
$22
Grifols USA, LLC
$20
HARMONY BIOSCIENCES LLC
$19
Life Molecular Imaging Ltd
$18
Eisai Inc.
$16
Currax Pharmaceuticals LLC
$16
Kedrion Biopharma, Inc.
$13
Top 3 companies account for 36.4% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,202
EMD Serono, Inc.
$1,096
Teva Pharmaceuticals USA, Inc.
$1,002
MDD US Operations, LLC
$955
Biogen, Inc.
$935
SK Life Science, Inc.
$790
Novartis Pharmaceuticals Corporation
$788
Adamas Pharmaceuticals, Inc.
$685
Supernus Pharmaceuticals, Inc.
$613
Lilly USA, LLC
$547
CSL Behring
$498
PFIZER INC.
$482
AbbVie Inc.
$477
ABBVIE INC.
$445
Avanir Pharmaceuticals, Inc.
$388
Celgene Corporation
$380
Allergan Inc.
$366
Eisai Inc.
$359
GENZYME CORPORATION
$346
Sunovion Pharmaceuticals Inc.
$344
Alexion Pharmaceuticals, Inc.
$321
US WorldMeds, LLC
$299
Sumitomo Pharma America, Inc.
$295
Genentech USA, Inc.
$266
Lundbeck LLC
$264
Mallinckrodt LLC
$261
Grifols USA, LLC
$241
Amgen Inc.
$225
Alnylam Pharmaceuticals Inc.
$212
ACADIA Pharmaceuticals Inc
$199
Takeda Pharmaceuticals U.S.A., Inc.
$197
Boston Scientific Corporation
$193
EISAI INC.
$184
BOSTON SCIENTIFIC CORPORATION
$163
Amneal Pharmaceuticals LLC
$157
Kyowa Kirin, Inc.
$154
Mallinckrodt Enterprises LLC
$145
Otsuka America Pharmaceutical, Inc.
$138
Biohaven Pharmaceutical Holding Company Ltd.
$136
CATALYST PHARMACEUTICALS, INC.
$130
Mallinckrodt Hospital Products Inc.
$127
Neurelis, Inc.
$122
Acorda Therapeutics, Inc
$110
LivaNova USA, Inc.
$96
E.R. Squibb & Sons, L.L.C.
$90
Vanda Pharmaceuticals Inc.
$76
Medtronic USA, Inc.
$74
Axsome Therapeutics, Inc.
$69
Impax Laboratories, Inc.
$56
ARBOR PHARMACEUTICALS, INC.
$55
SCILEX PHARMACEUTICALS INC.
$47
SANOFI-AVENTIS U.S. LLC
$47
GE HEALTHCARE
$45
Biohaven Pharmaceuticals, Inc.
$45
Janssen Pharmaceuticals, Inc
$44
NEUROPACE, INC.
$38
Medtronic Vascular, Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$35
Exeltis, USA Inc.
$30
Inspire Medical Systems, Inc.
$29
Merz Pharmaceuticals, LLC
$27
Shire North American Group Inc
$24
INSIGHTEC,INC
$24
Upsher-Smith Laboratories LLC
$23
Mylan Pharmaceuticals Inc.
$22
ARGENX US, INC.
$22
HARMONY BIOSCIENCES LLC
$19
Life Molecular Imaging Ltd
$18
Currax Pharmaceuticals LLC
$16
JAZZ PHARMACEUTICALS INC.
$16
Allergan, Inc.
$14
Kedrion Biopharma, Inc.
$13
GE Healthcare
$13
Neurocrine Biosciences, Inc.
$13
Top 3 companies account for 17.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AGAMREE · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Albuked · Apokyn · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · COMIRNATY · COPAXONE · DAYBUE · EMGALITY · EPIDIOLEX · Enspryng · Exablate · FABRY-DISEASE · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gocovri · HETLIOZ · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KISUNLA · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NEXVIAZYME · NO PRODUCT DISCUSSED · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · PAXLOVID · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · REYVOW · RNS Neurostimulator Kit · RYTARY · Rebif · Reveal LINQ · Rystiggo · SOLIRIS · Sunosi · TECFIDERA · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · UBRELVY · ULTOMIRIS · VALTOCO · VIIBRYD · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART · WAKIX · WATCHMAN · XADAGO · XCOPRI · Xadago · Xembify · Xeomin · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
100
Per 100K population
17.3
County median income
$84,198
Nearest hospital
SAINT ANNE'S HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Douglas is a clinical cardiology specialist, with above-average Medicare volume (top 21% in MA), with low-engagement industry engagement in the top 19% of MA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Douglas experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Douglas performed 320 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Douglas receive payments from pharmaceutical companies?
Yes. Dr. Douglas received a total of $18,409 from 74 companies across 944 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Douglas's costs compare to other neurologists in Fall River?
Dr. Douglas's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Douglas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Fall River
Browse neurologists in Fall River ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MA
Which MA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology